Biomarker ID | 768 |
PMID | 21963599 |
Year | 2012 |
Biomarker | OPNb (osteopontin -b ) |
Biomarker Basis | Expression Based |
Biomolecule | mRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Upregulated with high Gleason Score (Median for GS< 7: 3.54, Median for GS ≥ 7: 61.19) |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:-Alpha-V beta-3 integrin/OPN pathway,TWEAK regulation of gene expression,Osteopontin signaling,Osteoclast signaling,Beta-3 integrin cell surface interactions |
Experiment | Gleason Score <7 Vs Gleason Score ≥ 7 |
Type of Biomarker | Prognostic |
Cohort | 40 patients with PCA such as 15 have GS <7 and 25 has GS ≥ 7 |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p = 0.003 |
Method Used | Quantitative real time PCR (qRT-PCR) |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | SPP1 |